APA (7th ed.) Citation

SK, T., A, G., NP, D., Y, H., P, K., Y, C., . . . DJ, R. (2025). HLA-A2 CAR/IL-2-CISC engineered Treg display robust in vitro and in vivo antigen-specific regulatory function. Molecular therapy. Methods & clinical development, 33(3), 101561. https://doi.org/10.1016/j.omtm.2025.101561

Chicago Style (17th ed.) Citation

SK, Tripathi, Grimm A, Dahl NP, Honaker Y, Knebusch P, Chen Y, Cook PJ, and Rawlings DJ. "HLA-A2 CAR/IL-2-CISC Engineered Treg Display Robust in Vitro and in Vivo Antigen-specific Regulatory Function." Molecular Therapy. Methods & Clinical Development 33, no. 3 (2025): 101561. https://doi.org/10.1016/j.omtm.2025.101561.

MLA (9th ed.) Citation

SK, Tripathi, et al. "HLA-A2 CAR/IL-2-CISC Engineered Treg Display Robust in Vitro and in Vivo Antigen-specific Regulatory Function." Molecular Therapy. Methods & Clinical Development, vol. 33, no. 3, 2025, p. 101561, https://doi.org/10.1016/j.omtm.2025.101561.